| H0001-0004 | Hydrocortisone Sodium Phosphate | 6000-74-4 | Salt / salt form |
| H0001-0012 | Cortisol Impurity B ((E)-17-deoxyaldehyde derivative) | 105562-12-7 | Impurity |
| H0001-0013 | Cortisol Impurity C ((Z)-17-deoxyaldehyde derivative) | 105562-13-8 | Impurity |
| H0001-0031 | Hydrocortisone EP Impurity J | 16755-04-7 | Impurity |
| H0001-0061 | Hydrocortisone Impurity 10 | 61376-87-2 | Impurity |
| H0001-0133 | Hydrocortisone Impurity 74 | 80753-80-6 | Impurity |
| H0001-0135 | Hydrocortisone Impurity 75 | 15714-29-1 | Impurity |
| H0001-0137 | Hydrocortisone Impurity 76 | 906350-69-4 | Impurity |
| H0001-0139 | Hydrocortisone Impurity 77 | 906350-73-0 | Impurity |
| H0001-0157 | Hydrocortisone Impurity 93 | 601-05-8 | Impurity |
| H0001-0169 | Hydrocortisone Acetate Impurity 103 | 114593-86-1 | Impurity |
| H0001-0192 | Hydrocortisone Impurity 117 | 97342-59-1 | Impurity |
| H0001-0195 | Hydrocortisone Impurity 121 | 49757-02-0 | Impurity |
| H0001-0197 | Hydrocortisone Impurity 139 | 3461-66-3 | Impurity |
| H0001-0204 | Hydrocortisone 17-Acetate-d4 | 134331-54-7 | Stable-isotope labelled analogue |
| H0001-0225 | (8S,13S,14S,17S)-17-(hydroxymethyl)-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2' | 141664-21-3 | Related substance |
| H0001-0241 | Hydrocortisone Impurity 65 | 39791-38-3 | Impurity |
| H0001-0248 | (17α)-17-Hydroxy-3-oxoandrosta-4,9(11)-diene-17-carboxylic Acid | 74041-67-1 | Related substance |
| H0001-0253 | (2'S,8S,9S,10R,11S,13S,14S,17R)-2'-ethyl-11-hydroxy-2'-methoxy-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-17,4'-[1,3]dioxane]-3,5'(2H)-dione | 3080322-37-5 | Related substance |
| H0001-0255 | (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(((3R,5R,8R,9S,10S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid | 56162-40-4 | Related substance |
| H0001-0257 | (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(((3R,5R,8S,9S,10S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-11-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid | 26312-91-4 | Related substance |
| H0001-0258 | (2S,6aS,6bR,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-(4-(3-Aminophenoxy)phenyl)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one | 2166378-92-1 | Related substance |
| H0001-0259 | (3R,5R,8S,9S,10S,13S,14S,17R)-3,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethylhexadecahydro-11H-cyclopenta[a]phenanthren-11-one | 53-05-4 | Related substance |
| H0001-0260 | (3S,5R,7S,8R,9S,10S,13S,14S)-3,7-dihydroxy-10,13-dimethylhexadecahydro-17H-cyclopenta[a]phenanthren-17-one | 25848-69-5 | Related substance |
| H0001-0261 | (3S,5S,8R,9S,10R,13S,14S,17S)-3,17-dihydroxy-10,13-dimethylhexadecahydro-6H-cyclopenta[a]phenanthren-6-one | 17328-37-9 | Related substance |
| H0001-0265 | (4aS,4bS,5aS,6aS,7R,9aS,9bS)-7-hydroxy-7-(2-hydroxyacetyl)-4a,6a-dimethyl-4,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(3H)-one | 10072-97-6 | Related substance |
| H0001-0266 | (5a,11B)-11-Hydroxy-17,20:20,21-bis[methylenebis(oxy)]-pregnan-3-one | 1056-08-2 | Related substance |
| H0001-0267 | (5R,8S,9S,10S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyltetradecahydro-3H-cyclopenta[a]phenanthrene-3,11(2H)-dione | 68-54-2 | Related substance |
| H0001-0268 | (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-(3-((3-Aminobenzyl)oxy)-2-fluoro-6-methylphenyl)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one | 2842165-72-2 | Related substance |
| H0001-0269 | (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-(4-(3-Aminobenzyl)phenyl)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one | 2166375-82-0 | Related substance |
| H0001-0270 | (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-10-(4-(4-(hydroxymethyl)benzyl)phenyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one | 2913231-72-6 | Related substance |
| H0001-0271 | (6aR,6bS,7S,8aS,8bS,10S,11aR,12aS,12bS)-10-(3-((3-Aminobenzyl)oxy)-2-fluoro-6-methylphenyl)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one | 2842165-73-3 | Related substance |
| H0001-0273 | (6R,8R,9S,10R,13S,14S,17R)-6,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 548-97-0 | Related substance |
| H0001-0279 | (6S,8R,9S,10R,13S,14S,17R)-6,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one | 76941-54-3 | Related substance |
| H0001-0280 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid | 1246818-21-2 | Related substance |
| H0001-0283 | (7R,8S,9S,10R,11S,13S,14S,17R)-7,11,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one | 3100114-20-0 | Related substance |
| H0001-0286 | (8R,9S,10R,11S,13S,14R,17R)-11,14,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 103795-84-2 | Related substance |
| H0001-0290 | (8R,9S,10R,13S,14S,17R)-17-(2-chloroacetyl)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 20380-16-9 | Related substance |
| H0001-0291 | (8R,9S,10R,13S,14S,17R)-17-(dimethylglycyl)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 22215-46-9 | Related substance |
| H0001-0292 | (8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl propionate | 2693-85-8 | Related substance |
| H0001-0293 | (8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid | 633-29-4 | Related substance |
| H0001-0298 | (8S,10S,13S,14S,17R)-17-(((chloromethyl)dimethylsilyl)oxy)-10,13-dimethyl-3-oxo-2,3,6,7,8,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile | 116846-74-3 | Related substance |
| H0001-0299 | (8S,10S,13S,14S,17R)-17-(2-chloroacetyl)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,10,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one | 75868-48-3 | Related substance |
| H0001-0301 | (8S,10S,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl propionate | 1059482-59-5 | Related substance |
| H0001-0302 | (8S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile | 83196-56-9 | Related substance |
| H0001-0303 | (8S,10S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,10,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one | 10184-70-0 | Related substance |
| H0001-0304 | (8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-17-(((fluoromethyl)thio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl 3-((S)-2-((S)-2-(2-bromoacetamido)propanamido)propanamido)-4-fluorobenzoate | 2688785-30-8 | Related substance |
| H0001-0306 | (8S,9R,10S,13S,14S,17R)-9,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 566-12-1 | Related substance |
| H0001-0308 | (8S,9S,10R,11R,13S,14S,17R)-17-acetyl-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 603-98-5 | Related substance |
| H0001-0311 | (8S,9S,10R,11S,13S,14S)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15-dodecahydro-3H-cyclopenta[a]phenanthren-3-one | 3103-16-0 | Related substance |
| H0001-0312 | (8S,9S,10R,11S,13S,14S,17R)-1,11,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 63229-60-7 | Related substance |
| H0001-0313 | (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 4484-94-0 | Related substance |
| H0001-0314 | (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-(2-oxopropoxy)acetyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 1233011-24-9 | Related substance |
| H0001-0316 | (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(4-methyl-1,3-dioxolane-2-carbonyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 103228-51-9 | Related substance |
| H0001-0319 | (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl butyrate | 72590-77-3 | Related substance |
| H0001-0322 | (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl butyrate | 13609-67-1 | Related substance |
| H0001-0323 | (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl dihydrogen phosphate | 220489-76-9 | Salt / salt form |
| H0001-0324 | (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl formate | 74040-97-4 | Related substance |
| H0001-0325 | (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl pentanoate | 57524-89-7 | Related substance |
| H0001-0331 | (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-2'-methoxy-10,13-dimethyl-2'-propyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-17,4'-[1,3]dioxane]-3,5'(2H)-dione | 13609-63-7 | Related substance |
| H0001-0334 | (8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-3-methoxy-5',5',10,13-tetramethyl-1,2,4',5',7,8,9,10,11,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3'-one | 1261254-51-6 | Related substance |
| H0001-0335 | (8S,9S,10R,11S,13S,14S,17R)-17-((R)-1,2-dihydroxyethyl)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 116-58-5 | Related substance |
| H0001-0336 | (8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 68473-77-8 | Related substance |
| H0001-0337 | (8S,9S,10R,11S,13S,14S,17R)-17-(2-((tert-butyldimethylsilyl)oxy)acetyl)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 146201-53-8 | Related substance |
| H0001-0338 | (8S,9S,10R,11S,13S,14S,17R)-17-(2-acetoxyacetyl)-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl butyrate | 74050-21-8 | Related substance |
| H0001-0339 | (8S,9S,10R,11S,13S,14S,17R)-17-(2-acetoxyacetyl)-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl pentanoate | 81456-46-4 | Related substance |
| H0001-0340 | (8S,9S,10R,11S,13S,14S,17R)-17-(2-acetoxyacetyl)-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl propionate | 74050-20-7 | Related substance |
| H0001-0343 | (8S,9S,10R,11S,13S,14S,17R)-17-Glycyl-11,17-dihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one hydrochloride | 744254-09-9 | Salt / salt form |
| H0001-0344 | (8S,9S,10R,11S,13S,14S,17R)-17-Hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-11-yl formate | 33762-00-4 | Related substance |
| H0001-0345 | (8S,9S,10R,11S,13S,14S,17R)-2'-butyl-11-hydroxy-2'-methoxy-10,13-dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-17,4'-[1,3]dioxane]-3,5'(2H)-dione | 61774-28-5 | Related substance |
| H0001-0353 | (8S,9S,10R,11S,13S,14S,17S)-17-(2,2-dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one | 1960421-03-7 | Related substance |
| H0001-0354 | (8S,9S,10R,13S,14S)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carbaldehyde | 102600-93-1 | Related substance |
| H0001-0356 | (8S,9S,10R,13S,14S,17R)-17-((R)-1,2-dihydroxyethyl)-17-hydroxy-10,13-dimethyl-1,6,7,8,9,10,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-3,11(2H)-dione | 116-59-6 | Related substance |
| H0001-0357 | (8S,9S,10R,13S,14S,17R)-17-((R)-1,2-dihydroxyethyl)-17-hydroxy-10,13-dimethyl-7,8,9,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthrene-3,11(6H)-dione | 600-92-0 | Related substance |
| H0001-0359 | (8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile | 132639-69-1 | Related substance |
| H0001-0360 | (8S,9S,10R,13S,14S,17R)-17-Hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-9,10,12,13,14,15,16,17-octahydro-3H-cyclopenta[a]phenanthrene-3,11(8H)-dione | 2427-65-8 | Related substance |
| H0001-0362 | (8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carbaldehyde | 6247-91-2 | Related substance |
| H0001-0367 | (R)-1-((8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethane-1,2-diyl diacetate | 4420-24-0 | Related substance |
| H0001-0368 | (R)-2-hydroxy-2-((8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)acetic acid | 27149-67-3 | Related substance |
| H0001-0369 | (R)-2-hydroxy-2-((8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethyl acetate | 111615-16-8 | Related substance |
| H0001-0370 | (S)-4-(2-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetamido)-5-((3-(4-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-8b-(2-(phosphonooxy)acetyl)-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)benzyl)phenyl)amino)-5-oxopentanoic Acid | 2345732-83-2 | Related substance |
| H0001-0371 | (S)-4-(2-(2-Bromoacetamido)acetamido)-5-((3-(4-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-8b-(2-(phosphonooxy)acetyl)-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)benzyl)phenyl)amino)-5-oxopentanoic Acid | 2344809-82-9 | Related substance |
| H0001-0372 | (S)-4-(2-(2-Bromoacetamido)acetamido)-5-((3-(4-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)benzyl)bicyclo[1.1.1]pentan-1-yl)amino)-5-oxopentanoic acid | 2734878-02-3 | Related substance |
| H0001-0373 | (S)-N-(3-(4-((2S,6aS,6bR,7S,8aS,8bS,10R,11aR,12aS,12bS)-2,6b-Difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)phenoxy)phenyl)-2-((S)-2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)propanamido)propanamide | 2166376-64-1 | Related substance |
| H0001-0374 | (Z)-4-(2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobut-2-enoic acid | 33767-18-9 | Related substance |
| H0001-0378 | 1-((3R,5R,8R,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxyethan-1-one | 68-60-0 | Related substance |
| H0001-0384 | 11,20-dihydroxy-4-pregnene-3-one-21-oic acid | 27149-68-4 | Related substance |
| H0001-0387 | 11beta,17,21-trihydroxypregn-4-ene-3,20-dione 21-(dihydrogen phosphate) | 3863-59-0 | Salt / salt form |
| H0001-0388 | 11beta,17,21-trihydroxypregn-4-ene-3,20-dione 21-hexanoate | 3593-96-2 | Related substance |
| H0001-0394 | 17,17-dimethyl-18-norandrosta-4,13-dien-3-one | 1971-59-1 | Related substance |
| H0001-0395 | 17-(2-Hydroxyacetyl)-10,13-dimethyl-3,6-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl pentanoate, (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy- | 123814-12-0 | Related substance |
| H0001-0396 | 17-Epihydrocortisone | 116907-82-5 | Related substance |
| H0001-0397 | 17-Hydroxy-21-(1-oxopropoxy)pregna-4,9(11)-diene-3,20-dione | 1142365-56-7 | Related substance |
| H0001-0398 | 17-Hydroxy-21-iodopregna-4,9(11)-diene-3,20-dione | 95816-38-9 | Related substance |
| H0001-0399 | 17-Hydroxy-3,11-dioxo-androst-4-ene-17β-carboxylic Acid | 3597-44-2 | Related substance |
| H0001-0400 | 2,2,2-Trifluoroacetic acid--rac-(R)-4-(2-aminoacetamido)-5-((3-(4-((6aS,6bS,7R,8aR,8bR,10S,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-8b-(2-(phosphonooxy)acetyl)-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)benzyl)phenyl)amino)-5-oxopentanoic acid (1/1) | 2734877-83-7 | Related substance |
| H0001-0401 | 2-((((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-ylidene)amino)oxy)acetic acid | 43188-86-9 | Related substance |
| H0001-0405 | 2-((10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,10,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 115098-60-7 | Related substance |
| H0001-0407 | 2-((2S,6aS,6bR,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-(4-(3-((S)-2-((S)-2-(2-Bromoacetamido)propanamido)propanamido)benzyl)phenyl)-2,6b-difluoro-7-hydroxy-6a,8a-dimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl dihydrogen phosphate | 2345733-40-4 | Salt / salt form |
| H0001-0408 | 2-((3R,5R,8S,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-11-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 17736-20-8 | Related substance |
| H0001-0410 | 2-((5R,8S,9S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 1499-59-8 | Related substance |
| H0001-0411 | 2-((5S,8S,9S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 3751-02-8 | Related substance |
| H0001-0412 | 2-((6S,7S,8S,9S,10R,11S,13S,14S,17R)-6-Bromo-7,11,17-trihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 117888-53-6 | Related substance |
| H0001-0414 | 2-((8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 96391-56-9 | Related substance |
| H0001-0415 | 2-((8S,10S,13S,14S)-10,13-dimethyl-3-oxo-2,3,6,7,8,10,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 23460-76-6 | Related substance |
| H0001-0417 | 2-((8S,10S,13S,14S,17R)-17-acetoxy-10,13-dimethyl-3-oxo-2,3,6,7,8,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 7780-63-4 | Related substance |
| H0001-0418 | 2-((8S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 7753-60-8 | Related substance |
| H0001-0421 | 2-((8S,9R,10S,11S,13S,14S,17R)-9-bromo-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 50733-54-5 | Related substance |
| H0001-0422 | 2-((8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl methanesulfonate | 382-65-0 | Related substance |
| H0001-0423 | 2-((8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 1250-97-1 | Related substance |
| H0001-0427 | 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetic acid | 57172-48-2 | Related substance |
| H0001-0428 | 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl 3-cyclopentylpropanoate | 508-99-6 | Related substance |
| H0001-0429 | 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl butyrate | 6677-99-2 | Related substance |
| H0001-0430 | 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl octanoate | 6678-14-4 | Related substance |
| H0001-0431 | 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl pentanoate | 6678-00-8 | Related substance |
| H0001-0432 | 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl propionate | 6677-98-1 | Related substance |
| H0001-0433 | 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl dihydrogen phosphate | 55029-73-7 | Salt / salt form |
| H0001-0434 | 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-6-methylene-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 22032-36-6 | Related substance |
| H0001-0436 | 2-((8S,9S,10R,11S,13S,14S,17R)-11-(formyloxy)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 33744-76-2 | Related substance |
| H0001-0438 | 2-((8S,9S,10R,11S,13S,14S,17R)-11-acetoxy-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 81968-66-3 | Related substance |
| H0001-0440 | 2-((8S,9S,10R,11S,13S,14S,17R)-17-acetoxy-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl propionate | 81456-43-1 | Related substance |
| H0001-0442 | 2-((8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 2435-02-1 | Related substance |
| H0001-0443 | 2-((8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,6,11-trioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 96369-98-1 | Related substance |
| H0001-0446 | 2-((8S,9S,10R,13S,14S,17R)-17-Hydroxy-3-methoxy-10,13-dimethyl-11-oxo-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 97154-36-4 | Related substance |
| H0001-0447 | 2-((9R,10R,11S,13S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,9,10,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 72728-16-6 | Related substance |
| H0001-0451 | 2-((9S,10R,11S,13S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,9,10,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | 96843-89-9 | Related substance |
| H0001-0454 | 2-hydroxy-1-((3R,5R,8S,9S,10S,11S,13S,14S,17R)-3,11,17-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one | 53-02-1 | Related substance |
| H0001-0465 | 20-Dihydro-corticosterone 21-Carboxylic Acid | 75879-79-7 | Related substance |
| H0001-0466 | 21,21-Dichloro-17-hydroxy-pregna-4,9(11)-diene-3,20-dione | 116816-80-9 | Related substance |
| H0001-0467 | 21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxy-(11β,17α)-Pregn-4-ene-3,20-dione | 181229-50-5 | Related substance |
| H0001-0468 | 21-(Acetyloxy)-17-hydroxy-3-methoxypregna-3,5,9(11)-trien-20-one | 97154-22-8 | Related substance |
| H0001-0469 | 21-(Acetyloxy)-17-hydroxy-pregna-5,9(11)-diene-3,20-dione cyclic 3-(1,2-ethanediyl Acetal) | 24510-83-6 | Related substance |
| H0001-0470 | 21-(Acetyloxy)-3-ethoxy-17-hydroxypregna-3,5-diene-11,20-dione | 1852-65-9 | Related substance |
| H0001-0471 | 21-Acetyl-17,21-dihydroxy-pregna-4,8-diene-3,11,20-trione | 1856-26-4 | Related substance |
| H0001-0472 | 21-Deoxy Hydrocortisone | 34184-82-2 | Related substance |
| H0001-0473 | 3-((2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)carbonyl)benzenesulfonic acid | 35152-66-0 | Related substance |
| H0001-0474 | 3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((3-((2-fluoro-3-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)-4-methylphenoxy)methyl)phenyl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)propanamide | 3014393-37-1 | Related substance |
| H0001-0475 | 3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((3-((2-fluoro-3-((6aR,6bS,7S,8aS,8bS,10S,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)-4-methylphenoxy)methyl)phenyl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)propanamide | 3014393-35-9 | Related substance |
| H0001-0476 | 3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((3-(4-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)benzyl)phenyl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)propanamide | 2166376-51-6 | Related substance |
| H0001-0480 | 4-(((8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)oxy)-4-oxobutanoic acid | 220489-73-6 | Related substance |
| H0001-0481 | 4-(((8S,9S,10R,11S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-11-yl)oxy)-4-oxobutanoic acid | 146201-55-0 | Related substance |
| H0001-0482 | 4-(2-((8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid | 3331-69-9 | Related substance |
| H0001-0485 | 4-(2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid | 2203-97-6 | Related substance |
| H0001-0486 | 4-(2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid hydrate | 83784-20-7 | Related substance |
| H0001-0491 | 4-(2-((8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid | 10215-75-5 | Related substance |
| H0001-0494 | 4-oxo-4-(2-oxo-2-((6R,8S,9S,10R,11S,13S,14S,17R)-6,11,17-trihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethoxy)butanoic acid | 77106-62-8 | Related substance |
| H0001-0499 | 5α-Dihydrocortisol 21-Acetate | 4004-68-6 | Related substance |
| H0001-0506 | 6-Hydroxycortisol | 3078-34-0 | Related substance |
| H0001-0507 | 6alpha Methylhydrocortisone Aceponate | 83625-34-7 | Related substance |
| H0001-0508 | 6α-Hydroxy Cortisol | 2242-98-0 | Related substance |
| H0001-0510 | 9,17-Dihydroxycorticosterone 21-acetate | 50733-56-7 | Related substance |
| H0001-0516 | bis(2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl) hydrogen phosphate | 20513-23-9 | Salt / salt form |
| H0001-0517 | Butane-1,4-dione, 1-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2,3-dihydroxy-4-((8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl) | 21940-45-4 | Related substance |
| H0001-0519 | Corticosterone, 6-bromo-17-hydroxy-, 21-acetate | 909272-00-0 | Related substance |
| H0001-0521 | Cortisone 21-Valerate | 119698-10-1 | Related substance |
| H0001-0525 | Delta-9,-11 hydrocortisone hemisuccinate | 103497-66-1 | Related substance |
| H0001-0526 | Delta9(11)-Hydrocortisone 17-Valerate | 1903759-92-1 | Related substance |
| H0001-0527 | Epi Hydrocortisone Hemisuccinate | 103242-89-3 | Related substance |
| H0001-0536 | hydrocortisone 21-(sodium sulphate) | 1852-36-4 | Salt / salt form |
| H0001-0537 | Hydrocortisone 21-Aldehyde Hydrate (mixture of the aldehyde and the hydrated form) | 906337-64-2 | Related substance |
| H0001-0560 | Hydrocortisone Phosphate Triethylamine | 122764-80-1 | Salt / salt form |
| H0001-0567 | Hydrocortisone Sodium Sulfobenzoate | 33767-03-2 | Salt / salt form |
| H0001-0573 | HYDROCORTISONE-(1,2-3H(N)) | 3844-64-2 | Related substance |
| H0001-0581 | Pregn-4-ene-3,20-dione, 11,17-dihydroxy-6-methyl-, (6α,11β) | 7055-53-0 | Related substance |
| H0001-0582 | Pregn-4-ene-3,20-dione, 21-(acetyloxy)-6,7-epoxy-11,17-dihydroxy-, (6α,7α,11β) | 35875-74-2 | Related substance |
| H0001-0583 | Pregn-4-ene-3,20-dione, 6,11β,17,21-tetrahydroxy-, 21-acetate | 96391-38-7 | Related substance |
| H0001-0584 | Pregn-4-ene-3,20-dione, 6-bromo-11,17,21-trihydroxy-, (11β) | 111864-51-8 | Related substance |
| H0001-0585 | Pregn-4-ene-3,20-dione-2,2,9,11,12,12-d6, 11,17,21-trihydroxy-, (11β) | 2241864-40-2 | Stable-isotope labelled analogue |
| H0001-0586 | Pregna-1,4-diene-3,20-dione, 16,17-[[(R)-[4-[(3-aminophenyl)methyl]phenyl]methylene]bis(oxy)]-11-hydroxy-21-(phosphonooxy)-, (11β,16α)- | 3048601-02-8 | Related substance |
| H0001-0587 | Pregna-3,5-dien-20-one, 21-(acetyloxy)-11,17-dihydroxy-3-methoxy-, (11β) | 22067-18-1 | Related substance |
| H0001-0588 | Pregnane-3,20-dione, 21-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-11,17-dihydroxy-, (5α,11β) | 1242075-38-2 | Related substance |
| H0001-0593 | sodium 4-(2-((8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoate | 70795-33-4 | Salt / salt form |
| H0001-0594 | sodium 4-(2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoate | 125-04-2 | Salt / salt form |
| H0001-0595 | sodium 4-(2-((8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoate | 7415-42-1 | Salt / salt form |
| H0001-0603 | Hydrocortisone Impurity 10 | 16463-74-4 | Impurity |
| H0001-0604 | Hydrocortisone Impurity 11 | 640-87-9 | Impurity |
| H0001-0605 | Hydrocortisone Impurity 12 | 641-77-0 | Impurity |
| H0001-0606 | Hydrocortisone Impurity 13 | 566-35-8 | Impurity |
| H0001-0608 | Hydrocortisone Impurity 144 | 16355-28-5 | Impurity |
| H0001-0609 | Hydrocortisone Impurity 15 | 154032-37-8 | Impurity |
| H0001-0610 | Hydrocortisone Impurity 2 | 1257650-98-8 | Impurity |
| H0001-0612 | Hydrocortisone Impurity 4 | 53-35-0 | Impurity |
| H0001-0613 | Hydrocortisone Impurity 40 | 14760-49-7 | Impurity |
| H0001-0614 | Hydrocortisone Impurity 5 | 600-99-7 | Impurity |
| H0001-0615 | Hydrocortisone Impurity 6 | 152-58-9 | Impurity |
| H0001-0616 | Hydrocortisone Impurity 6 | 1258063-56-7 | Impurity |